PBI
68
2
SYY
45
-3
STI
18
11
AZO
42
-3
APH
56
7
SO
46
-5
STX
69
2
HBAN
82
3
MS
74
5
ADM
47
2
JBHT
65
2
LRCX
62
6
MRK
63
3
BF.B
48
-2
JPM
70
3
KLAC
72
2
CME
45
3
BEN
55
2
MCK
67
3
LYB
22
2
PBI
68
2
SYY
45
-3
STI
18
11
AZO
42
-3
APH
56
7
SO
46
-5
STX
69
2
HBAN
82
3
MS
74
5
ADM
47
2
JBHT
65
2
LRCX
62
6
MRK
63
3
BF.B
48
-2
JPM
70
3
KLAC
72
2
CME
45
3
BEN
55
2
MCK
67
3
LYB
22
2
Financhill
Back

Rhythm Pharmaceuticals, Inc. Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
46

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$112.11
Seasonality Move:
-13.08%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Rhythm Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Rhythm Pharmaceuticals, Inc. has on average historically risen by 37.5% based on the past 8 years of stock performance.
  • Rhythm Pharmaceuticals, Inc. has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
  • Is Rhythm Pharmaceuticals, Inc. Stock Undervalued?
    The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $112.14. The Score for RYTM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Rhythm Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Rhythm Pharmaceuticals, Inc. has on average historically risen by 37.5% based on the past 8 years of stock performance.

Rhythm Pharmaceuticals, Inc. Stock Rating

Sell
46
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. overpriced?

  • Rhythm Pharmaceuticals, Inc. has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%

Rhythm Pharmaceuticals, Inc. Stock Price History

Is RYTM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rhythmtx.com

52-Week Data

52-Week High:
122.20
52-Week Low:
45.91

Prediction Charts

Market Cap:
7.5B
Price in USD:
112.14
Volume:
1.4M
Beta:
1.81

Technical Analysis

SMA50:
106.41
SMA100:
102.18
SMA200:
83.22
52-Wk Change:
102.13%

Stock Predictions

  • Is Rhythm Pharmaceuticals, Inc. stock public?
    Yes, Rhythm Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Rhythm Pharmaceuticals, Inc. stock quote today?
    The Rhythm Pharmaceuticals, Inc. stock price is 112.14 USD today.
  • How to buy Rhythm Pharmaceuticals, Inc. stock online?
    You can buy Rhythm Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 105.04 101.39 106.06 101.00
Dec-3 101.70 104.63 105.76 101.22
Dec-4 104.63 105.70 107.57 102.76
Dec-5 105.70 104.60 106.76 103.59
Dec-8 106.47 105.18 106.47 104.08
Dec-9 104.58 100.71 105.72 100.37
Dec-10 101.15 104.77 105.97 99.96
Dec-11 113.73 117.62 122.20 111.00
Dec-12 119.58 113.56 119.58 109.59
Dec-15 112.42 112.52 116.34 111.39
Dec-16 111.41 112.45 114.46 111.37
Dec-17 113.19 111.86 115.05 109.99
Dec-18 112.28 111.73 113.07 110.30
Dec-19 112.00 112.14 115.00 110.54

Rhythm Pharmaceuticals, Inc. Earnings

Rhythm Pharmaceuticals, Inc. Earnings Report: Per Share Rhythm Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Rhythm Pharmaceuticals, Inc. Forecast Revenue Growth

Rhythm Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Rhythm Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

* Rhythm Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.